Key patient related factors in the management of inflammatory bowel disease

J Med Econ. 2020 Dec;23(12):1606-1609. doi: 10.1080/13696998.2020.1838913. Epub 2020 Nov 19.

Eleonora Allocati¹, Brian Godman^{2

3

4

5}

¹ Istituto di Ricerche Farmacologiche 'Mario Negri' IRCCS, Milan, Italy.
² Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
³ School of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
⁴ Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
⁵ Pharmaceutical Sciences Department, Universiti Sains Malaysia, Penang, Malaysia.

No abstract available

Publication types